title: Biosimilar G-CSF (filgrastim) is effective for peripheral blood stem cell mobilization and non-cryopreserved autologous transplantation.
authors.affiliation: Hematology and Cell Therapy Department, Establishment Hospital University 1st November, Oran, Algeria. Electronic address: yafour.nabil@yahoo.fr.
authors.forename: N
authors.initials: N
authors.lastname: Yafour
authors.forename: M
authors.initials: M
authors.lastname: Brahimi
authors.forename: S
authors.initials: S
authors.lastname: Osmani
authors.forename: A
authors.initials: A
authors.lastname: Arabi
authors.forename: R
authors.initials: R
authors.lastname: Bouhass
authors.forename: M A
authors.initials: MA
authors.lastname: Bekadja
mesh_terms: D000293:Adolescent; D000328:Adult; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D059451:Biosimilar Pharmaceuticals / Q000494:pharmacology*; D001772:Blood Cell Count; D001793:Blood Preservation; D003131:Combined Modality Therapy; D017046:Cost Savings; D005260:Female; D000069585:Filgrastim; D016179:Granulocyte Colony-Stimulating Factor / Q000191:economics / Q000494:pharmacology*; D019337:Hematologic Neoplasms / Q000097:blood / Q000188:drug therapy / Q000601:surgery; D019650:Hematopoietic Stem Cell Mobilization / Q000191:economics; D006801:Humans; D007937:Leukapheresis; D008297:Male; D008875:Middle Aged; D036102:Peripheral Blood Stem Cell Transplantation; D011446:Prospective Studies; D011994:Recombinant Proteins / Q000191:economics / Q000494:pharmacology; D014182:Transplantation, Autologous; D055815:Young Adult
chemical_list: D059451:Biosimilar Pharmaceuticals; D011994:Recombinant Proteins; D016179:Granulocyte Colony-Stimulating Factor; D000069585:Filgrastim